China Tian Yuan Healthcare Group Limited(HK:0557)
HK$0.44-0.04 (-9.38%)
HK:0557
China Tian Yuan Healthcare Group Limited financials statements
HK$0.44
At close:-0.04 (-9.38%)
Want to see HK:0557 full AI Analyst Report?
China Tian Yuan Healthcare Group Limited (0557) Ratios
1 Followers
China Tian Yuan Healthcare Group Limited Ratios
HK:0557's free cash flow for Q2 2026 was HK$4.22M. For the 2026 fiscal year, HK:0557's free cash flow was decreased by HK$-1.49M and operating cash flow was HK$5.71M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.13 | 3.55 | 3.92 | 4.29 | 6.02 |
| Quick Ratio | 3.10 | 3.53 | 3.91 | 4.25 | 5.95 |
| Cash Ratio | 0.51 | 0.50 | 0.45 | 0.60 | 1.81 |
| Solvency Ratio | -0.29 | -0.31 | -0.07 | -0.21 | -0.05 |
| Operating Cash Flow Ratio | 0.17 | 0.22 | 0.11 | -0.69 | 0.45 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 2.06 | 1.18 | -7.47 | 4.19 |
| Net Current Asset Value | HK$ 82.28M | HK$ 89.80M | HK$ 93.48M | HK$ 98.30M | HK$ 126.43M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.17 | 0.18 | 0.15 | 0.15 | 0.16 |
| Debt-to-Equity Ratio | 0.24 | 0.24 | 0.20 | 0.23 | 0.23 |
| Debt-to-Capital Ratio | 0.19 | 0.19 | 0.17 | 0.19 | 0.19 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.40 | 1.34 | 1.32 | 1.49 | 1.47 |
| Debt Service Coverage Ratio | -0.96 | -3.26 | -1.78 | -1.39 | -0.71 |
| Interest Coverage Ratio | -4.04 | -2.29 | -6.44 | -5.71 | -3.88 |
| Debt to Market Cap | 0.00 | 0.03 | 0.02 | 0.01 | 0.01 |
| Interest Debt Per Share | 0.10 | 0.12 | 0.12 | 0.14 | 0.16 |
| Net Debt to EBITDA | -3.13 | -0.79 | -1.58 | -1.88 | 2.09 |
| Profitability Margins | |||||
| Gross Profit Margin | 50.00% | 55.56% | 55.24% | 64.23% | 75.39% |
| EBIT Margin | -63.01% | -131.11% | -54.99% | -41.70% | -15.60% |
| EBITDA Margin | -18.31% | -101.39% | -34.92% | -24.12% | -3.06% |
| Operating Profit Margin | -63.01% | -27.45% | -50.45% | -41.70% | -18.42% |
| Pretax Profit Margin | -203.70% | -143.10% | -63.63% | -74.42% | -20.15% |
| Net Profit Margin | -177.36% | -127.54% | -34.23% | -53.56% | -17.82% |
| Continuous Operations Profit Margin | -200.31% | -143.76% | -59.60% | -74.42% | -20.15% |
| Net Income Per EBT | 87.07% | 89.13% | 53.80% | 71.96% | 88.41% |
| EBT Per EBIT | 323.29% | 521.38% | 126.11% | 178.47% | 109.40% |
| Return on Assets (ROA) | -15.12% | -13.12% | -5.11% | -8.71% | -4.48% |
| Return on Equity (ROE) | -21.10% | -17.59% | -6.72% | -12.95% | -6.58% |
| Return on Capital Employed (ROCE) | -7.09% | -3.48% | -8.89% | -7.81% | -5.12% |
| Return on Invested Capital (ROIC) | -6.78% | -3.32% | -8.05% | -7.24% | -5.01% |
| Return on Tangible Assets | -15.85% | -15.30% | -6.50% | -11.04% | -5.70% |
| Earnings Yield | -12.18% | -16.50% | -7.61% | -5.82% | -4.35% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.14 | 0.18 | 0.29 | 0.35 | 0.68 |
| Payables Turnover | 2.86 | 3.24 | 4.64 | 5.36 | 74.62 |
| Inventory Turnover | 6.15 | 14.95 | 25.06 | 9.84 | 9.33 |
| Fixed Asset Turnover | 0.58 | 0.71 | 1.04 | 1.07 | 1.55 |
| Asset Turnover | 0.09 | 0.10 | 0.15 | 0.16 | 0.25 |
| Working Capital Turnover Ratio | 0.16 | 0.21 | 0.32 | 0.33 | 0.51 |
| Cash Conversion Cycle | 2588.04 | 1909.59 | 1176.39 | 1020.97 | 568.25 |
| Days of Sales Outstanding | 2656.44 | 1997.92 | 1240.49 | 1051.95 | 534.04 |
| Days of Inventory Outstanding | 59.34 | 24.41 | 14.57 | 37.08 | 39.10 |
| Days of Payables Outstanding | 127.74 | 112.74 | 78.66 | 68.06 | 4.89 |
| Operating Cycle | 2715.78 | 2022.34 | 1255.06 | 1089.04 | 573.15 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.02 | 0.03 | 0.01 | -0.08 | 0.04 |
| Free Cash Flow Per Share | 0.02 | 0.03 | 0.01 | -0.08 | 0.04 |
| Dividend Paid and CapEx Coverage Ratio | 32.22 | 628.82 | 8.57 | -22.52 | 11.19 |
| Capital Expenditure Coverage Ratio | 32.22 | 628.82 | 8.57 | -22.52 | 11.19 |
| Operating Cash Flow Coverage Ratio | 0.24 | 0.23 | 0.11 | -0.59 | 0.27 |
| Operating Cash Flow to Sales Ratio | 0.49 | 0.40 | 0.11 | -0.56 | 0.17 |
| Free Cash Flow Yield | 3.26% | 5.14% | 2.21% | -6.36% | 3.84% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -8.21 | -6.06 | -13.14 | -17.18 | -22.96 |
| Price-to-Sales (P/S) Ratio | 14.56 | 7.73 | 4.50 | 9.20 | 4.09 |
| Price-to-Book (P/B) Ratio | 1.73 | 1.07 | 0.88 | 2.22 | 1.51 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 30.63 | 19.44 | 45.15 | -15.73 | 26.05 |
| Price-to-Operating Cash Flow Ratio | 29.68 | 19.41 | 39.88 | -16.43 | 23.72 |
| Price-to-Earnings Growth (PEG) Ratio | 14.08 | -0.05 | 0.28 | -0.24 | 0.31 |
| Enterprise Value Multiple | -82.65 | -8.41 | -14.47 | -40.02 | -131.78 |
| Enterprise Value | 290.27M | 228.97M | 228.51M | 523.36M | 380.97M |
| EV to EBITDA | -82.65 | -8.41 | -14.47 | -40.02 | -131.78 |
| EV to Sales | 15.14 | 8.53 | 5.05 | 9.65 | 4.03 |
| EV to Free Cash Flow | 31.84 | 21.45 | 50.70 | -16.50 | 25.64 |
| EV to Operating Cash Flow | 30.85 | 21.42 | 44.79 | -17.24 | 23.35 |
| Tangible Book Value Per Share | 0.32 | 0.35 | 0.38 | 0.43 | 0.51 |
| Shareholders’ Equity Per Share | 0.40 | 0.49 | 0.58 | 0.56 | 0.64 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.02 | -0.00 | 0.06 | 0.05 | -0.16 |
| Revenue Per Share | 0.05 | 0.07 | 0.11 | 0.14 | 0.24 |
| Net Income Per Share | -0.09 | -0.09 | -0.04 | -0.07 | -0.04 |
| Tax Burden | 0.87 | 0.89 | 0.54 | 0.72 | 0.88 |
| Interest Burden | 3.23 | 1.09 | 1.16 | 1.78 | 1.29 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 1.62 | 0.83 | 0.90 | 1.04 | 0.95 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.28 | -0.31 | -0.33 | 0.75 | -0.86 |
Currency in HKD
